DEF 14A PROXY

Company

Cartesian Therapeutics, Inc.

Filed

April 28, 2020

Period of Report

December 31, 2019

Accession Number

0001453687-20-000040

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →